Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant
2008

Blocking AP-1 Reduces Lung Cancer Cell Growth

publication Evidence: moderate

Author Information

Author(s): Shimizu Y, Kinoshita I, Kikuchi J, Yamazaki K, Nishimura M, Birrer M J, Dosaka-Akita H

Primary Institution: Hokkaido University Graduate School of Medicine

Hypothesis

The study aims to determine the effects of AP-1 blockade on the growth of non-small cell lung cancer (NSCLC) cells using a cJun dominant-negative mutant.

Conclusion

The study found that AP-1 blockade significantly inhibits the growth of certain NSCLC cells both in vitro and in vivo.

Supporting Evidence

  • TAM67 inhibited AP-1 transcriptional activity in NSCLC cell lines.
  • TAM67 reduced anchorage-dependent and -independent growth of H1299 cells.
  • Induction of TAM67 led to G1 cell-cycle arrest without inducing apoptosis.
  • TAM67 significantly decreased the expression of cyclin A.

Takeaway

This study shows that blocking a specific protein can help stop lung cancer cells from growing.

Methodology

The study used transient transfection of a dominant-negative cJun mutant (TAM67) in NSCLC cell lines and assessed its effects on cell growth and AP-1 activity.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1038/sj.bjc.6604267

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication